MAXWELL LINDA
SEC insider (Form 3/4/5 filer). CIK 0001822674. Director at UNITED THERAPEUTICS Corp (UTHR) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 22, 2026. Located in SILVER SPRING, MD.
Companies MAXWELL LINDA has filed insider reports for
- UNITED THERAPEUTICS Corp (UTHR): Director
- ImmunityBio, Inc. (IBRX): Director
MAXWELL LINDA
CIK: 0001822674
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jul 22, 2026UTHR
UNITED THERAPEUTICS Corp
AwardDirectRestricted Stock Unit
380 shares- - Jul 22, 2026UTHR
UNITED THERAPEUTICS Corp
AwardDirectStock Option
1.2K shares- - Jun 9, 2026IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
65.6K shares- - Jul 24, 2025UTHR
UNITED THERAPEUTICS Corp
AwardDirectStock Options
3.7K shares- - Jun 18, 2025IBRX
ImmunityBio, Inc.
AwardDirectStock Option (right to buy)
162.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 22, 2026 |  UTHR UNITED THERAPEUTICS Corp | Award Restricted Stock Unit | 380 | - | - | Direct |
| Jul 22, 2026 | UTHR UNITED THERAPEUTICS Corp | Award Stock Option | 1,190 | - | - | Direct |
| Jun 9, 2026 |  IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 65,600 | - | - | Direct |
| Jul 24, 2025 | UTHR UNITED THERAPEUTICS Corp | Award Stock Options | 3,650 | - | - | Direct |
| Jun 18, 2025 | IBRX ImmunityBio, Inc. | Award Stock Option (right to buy) | 162,786 | - | - | Direct |
1-5 of 5 transactions